NCT03748134 2023-10-24Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )Innovent Biologics (Suzhou) Co. Ltd.Phase 3 Completed746 enrolled
NCT00382031 2013-10-15Zalutumumab in Patients With Non-curable Head and Neck CancerGenmabPhase 3 Completed286 enrolled 12 charts